articleTop 1% cited

RECIST 1.1—Update and clarification: From the RECIST committee

European Journal of Cancer · 2016 · Vol. 62 · pp. 132–137

Lawrence H. Schwartz✉(NewYork–Presbyterian Hospital)Saskia Litière(European Organisation for Research and Treatment of Cancer)Elisabeth G.E. de Vries(University Medical Center Groningen)Robert Ford(Clinical Research Consulting)Stephen J. Gwyther(East Surrey Hospital)Sumithra J. Mandrekar(Mayo Clinic)Lalitha Shankar(National Cancer Institute)Jan Bogaerts(European Organisation for Research and Treatment of Cancer)Alice P. Chen(National Cancer Institute)Janet Dancey(Queen's University)Wendy Hayes(Bristol-Myers Squibb (United States))F. Stephen Hodi(Harvard University)Otto S. Hoekstra(Amsterdam UMC Location Vrije Universiteit Amsterdam)Erich P. Huang(National Institutes of Health)Nancy U. Lin(Harvard University)Yan Liu(European Organisation for Research and Treatment of Cancer)Patrick Therasse(Servier (France))Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center)Lesley Seymour(Queen's University)

View via DOI Publisher page

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Pancreatic and Hepatic Oncology ResearchResponse Evaluation Criteria in Solid TumorsMedicineMedical physicsRadiologyDiseaseProgressive diseaseInternal medicine

MeSH terms

HumansLymph NodesNeoplasmsTomography, X-Ray ComputedTreatment OutcomeDisease ProgressionAdvisory CommitteesResponse Evaluation Criteria in Solid Tumors